Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
出版年份 2021 全文链接
标题
Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination
作者
关键词
-
出版物
ZEITSCHRIFT FUR RHEUMATOLOGIE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-07
DOI
10.1007/s00393-021-01055-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impfung gegen SARS-CoV-2 bei entzündlich rheumatischen Erkrankungen
- (2021) C. Specker et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
- (2021) Hannah Bower et al. ANNALS OF THE RHEUMATIC DISEASES
- Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2021) Anja Strangfeld et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
- (2021) Martin Schäfer et al. ANNALS OF THE RHEUMATIC DISEASES
- Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in times of SARS-CoV-2—methodology, key messages and justifying information
- (2021) Hendrik Schulze-Koops et al. RHEUMATOLOGY
- COVID-19 vaccination and antirheumatic therapy
- (2021) Jack Arnold et al. RHEUMATOLOGY
- Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis
- (2021) Qingxiu Wang et al. RHEUMATOLOGY INTERNATIONAL
- Aktueller Stand der Impfung gegen SARS-CoV-2
- (2021) Christof Iking-Konert et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Impact of Biological Therapies on the Immune Response after Pneumococcal Vaccination in Patients with Autoimmune Inflammatory Diseases
- (2021) Patricia Richi et al. Vaccines
- Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
- (2021) Caoilfhionn M Connolly et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
- (2021) Michael Markus Bonelli et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
- (2021) David Simon et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab, but not other antirheumatic therapies, is associated with impaired serological response to SARS- CoV-2 vaccination in patients with rheumatic diseases
- (2021) Robert Spiera et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- Prothrombotic immune thrombocytopenia after COVID-19 vaccine
- (2021) Andreas Tiede et al. BLOOD
- Risk of Severe COVID-19 Infection in Patients With Inflammatory Rheumatic Diseases
- (2021) Javier Bachiller-Corral et al. JOURNAL OF RHEUMATOLOGY
- An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination
- (2021) Ingvild Hausberg Sørvoll et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
- (2021) Tom T. Shimabukuro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
- (2021) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
- (2021) Andreas Greinacher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for severe outcomes in patients with systemic vasculitis & COVID‐19: a bi‐national registry‐based cohort study
- (2021) Matthew A Rutherford et al. Arthritis & Rheumatology
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1
- (2021) Jeffrey R Curtis et al. Arthritis & Rheumatology
- Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
- (2021) Jeffrey A Sparks et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
- (2021) Jérôme Avouac et al. Lancet Rheumatology
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- (2020) Michael Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
- (2020) Philippe Guilpain et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- No advice to discontinue antirheumatic therapy for non-medical reasons in light of SARS-CoV-2. Response to: ‘Treatment adherence of patients with sytemic rheumatic diseases in COVID-19 pandemic’ by Fragoulis et al
- (2020) Hendrik Schulze-Koops et al. ANNALS OF THE RHEUMATIC DISEASES
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aktuelle Handlungsempfehlungen der Deutschen Gesellschaft für Rheumatologie für die Betreuung von Patienten mit rheumatischen Erkrankungen während der SARS-CoV‑2/Covid 19-Pandemie
- (2020) H. Schulze-Koops et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Covid-19: risk factors for severe disease and death
- (2020) Rachel E Jordan et al. BMJ-British Medical Journal
- Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
- (2020) Jose L Pablos et al. ANNALS OF THE RHEUMATIC DISEASES
- Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab
- (2020) Jérôme Avouac et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
- (2020) Hendrik Schulze-Koops et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases
- (2020) Dalifer D Freites Nuñez et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients
- (2020) M. Zen et al. JOURNAL OF AUTOIMMUNITY
- COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients
- (2020) Dr. Giuseppe A. Ramirez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Long, relapsing, and atypical symptomatic course of COVID-19 in a B-cell-depleted patient after rituximab
- (2020) Jan Leipe et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
- (2020) Xabier Michelena et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series
- (2020) Clodoveo Ferri et al. CLINICAL RHEUMATOLOGY
- Do immunosuppressive agents hamper the vaccination response in patients with rheumatic diseases? A review of the literature
- (2020) Dorra Ben Nessib et al. THERAPIE
- SARS-CoV-2 & Rheuma
- (2020) J. Leipe et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients
- (2020) ANNALS OF THE RHEUMATIC DISEASES
- Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
- (2020) Naomi Serling-Boyd et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and severeness of COVID-19 hospitalisation in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
- (2020) René Cordtz et al. RHEUMATOLOGY
- Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial
- (2019) Jin Kyun Park et al. ANNALS OF THE RHEUMATIC DISEASES
- Trial of Tocilizumab in Giant-Cell Arteritis
- (2017) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Safety and Immunogenicity of Live Zoster Vaccination in Patients With Rheumatoid Arthritis Before Starting Tofacitinib: A Randomized Phase II Trial
- (2017) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
- (2016) Rieke Alten et al. BMC MUSCULOSKELETAL DISORDERS
- Infection Risk and Safety of Corticosteroid Use
- (2016) Jameel Youssef et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
- (2015) Kevin L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study
- (2015) Lara Fischer et al. ARTHRITIS RESEARCH & THERAPY
- Vaccine Responses in Patients with Rheumatoid Arthritis Treated with Certolizumab Pegol: Results from a Single-blind Randomized Phase IV Trial
- (2014) A. J. Kivitz et al. JOURNAL OF RHEUMATOLOGY
- Vaccination of patients with autoimmune inflammatory rheumatic diseases
- (2014) Johanna Westra et al. Nature Reviews Rheumatology
- The Risk of Systemic Lupus Erythematosus Associated With Vaccines: An International Case-Control Study
- (2014) Lamiae Grimaldi-Bensouda et al. Arthritis & Rheumatology
- Immune response to influenza vaccine and pneumococcal polysaccharide vaccine under IL-6 signal inhibition therapy with tocilizumab
- (2013) Tomomi Tsuru et al. Modern Rheumatology
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
- (2013) Meliha Crnkic Kapetanovic et al. ARTHRITIS RESEARCH & THERAPY
- Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis
- (2012) Shunsuke Mori et al. ANNALS OF THE RHEUMATIC DISEASES
- Abatacept and reduced immune response to pandemic 2009 influenza A/H1N1 vaccination in patients with rheumatoid arthritis
- (2012) Ana C. Ribeiro et al. ARTHRITIS CARE & RESEARCH
- Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate
- (2011) E. Coulson et al. ANNALS OF THE RHEUMATIC DISEASES
- High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis
- (2011) K. Au et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
- (2011) Cem Gabay et al. ARTHRITIS AND RHEUMATISM
- Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study
- (2011) S. Adler et al. RHEUMATOLOGY
- The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab
- (2011) U. Arad et al. VACCINE
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
- The Effect of Infliximab and Timing of Vaccination on the Humoral Response to Influenza Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
- (2009) Ori Elkayam et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Antibody Response to Influenza Immunization in Kidney Transplant Recipients Receiving either Azathioprine or Mycophenolate: A Controlled Trial
- (2008) Maryam Keshtkar-Jahromi et al. AMERICAN JOURNAL OF NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now